EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Ketamine for Depression, 3: Does Chirality Matter?

Chittaranjan Andrade

The Journal of Clinical Psychiatry · 28.06.2017 · 78 (06) · e674-e677

DOI: 10.4088/jcp.17f11681 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift The Journal of Clinical Psychiatry, erschienen am 28.06.2017. Verfasst von Chittaranjan Andrade. Beteiligte Einrichtung: Department of Psychopharmacology, National Institute of Mental Health and Neurosciences, Bangalore, India. candrade@psychiatrist.com. Hauptthemen laut MEDLINE: Stereoisomerism. Die Arbeit wurde bisher 72-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

StereoisomerismAnimalsAntidepressive AgentsDepressive Disorder, Treatment-ResistantHumansKetamine

Substanzen

Antidepressive AgentsKetamine

Autor:innen und Institutionen

  • Department of Psychopharmacology, National Institute of Mental Health and Neurosciences, Bangalore, India. candrade@psychiatrist.com.

Zitieren

APA

Andrade, C. (2017). Ketamine for Depression, 3: Does Chirality Matter?. The Journal of Clinical Psychiatry, 78(06), e674-e677. https://doi.org/10.4088/jcp.17f11681

Vancouver

Andrade C. Ketamine for Depression, 3: Does Chirality Matter?. The Journal of Clinical Psychiatry. 2017;78(06):e674-e677. doi:10.4088/jcp.17f11681

BibTeX
@article{Andrade2017,
  author = {Andrade, Chittaranjan},
  title = {Ketamine for Depression, 3: Does Chirality Matter?},
  journal = {The Journal of Clinical Psychiatry},
  year = {2017},
  volume = {78},
  number = {06},
  pages = {e674--e677},
  doi = {10.4088/jcp.17f11681}
}
Kostenlos starten →